drugset / Trial / NCT04854551
Opioid Modulation and Neural Reward Activation in Healthy Adults
RandomizedCrossoverTriple-blindBasic science
Summary
This is a double blind study of the effects of opioid antagonism on the brain's reward response. The investigators will recruit participants to undergo two scans, one on active medication and one on placebo. During the scan, the investigators will assess reward.
Timeline
- Start
- 2021-05-01
- Primary completion
- 2022-04-18
- Completion
- 2022-04-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 50 mg | — |